Home Healthcare Biotechnology Pediatric Vaccines Market

Pediatric Vaccines Market Size, Share & Trends Analysis Report By Type (Monovalent, Multivalent), By Technology (Live Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, Conjugate Vaccines, Others), By Application (Infectious Disease, Cancer, Allergy, Pneumococcal Diseases, Influenza, Measles, Mumps, and Rubella (MMR), Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: April 02, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Pediatric Vaccines Market Size Analysis
    1. Introduction
    2. Pediatric Vaccines Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Monovalent
      2. Multivalent
    3. Pediatric Vaccines Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Live Attenuated Vaccines
      2. Inactivated Vaccines
      3. Subunit Vaccines
      4. Toxoid Vaccines
      5. Conjugate Vaccines
      6. Others
    4. Pediatric Vaccines Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Infectious Disease
      2. Cancer
      3. Allergy
      4. Pneumococcal Diseases
      5. Influenza
      6. Measles, Mumps, and Rubella (MMR)
      7. Others
  7. North America Pediatric Vaccines Market Size Analysis
    1. Introduction
    2. Pediatric Vaccines Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Monovalent
      2. Multivalent
    3. Pediatric Vaccines Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Live Attenuated Vaccines
      2. Inactivated Vaccines
      3. Subunit Vaccines
      4. Toxoid Vaccines
      5. Conjugate Vaccines
      6. Others
    4. Pediatric Vaccines Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Infectious Disease
      2. Cancer
      3. Allergy
      4. Pneumococcal Diseases
      5. Influenza
      6. Measles, Mumps, and Rubella (MMR)
      7. Others
    5. U.S.
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    6. Canada
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
  8. Europe Pediatric Vaccines Market Size Analysis
    1. Introduction
    2. Pediatric Vaccines Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Monovalent
      2. Multivalent
    3. Pediatric Vaccines Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Live Attenuated Vaccines
      2. Inactivated Vaccines
      3. Subunit Vaccines
      4. Toxoid Vaccines
      5. Conjugate Vaccines
      6. Others
    4. Pediatric Vaccines Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Infectious Disease
      2. Cancer
      3. Allergy
      4. Pneumococcal Diseases
      5. Influenza
      6. Measles, Mumps, and Rubella (MMR)
      7. Others
    5. U.K.
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    6. Germany
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    7. France
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    8. Spain
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    9. Italy
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    10. Russia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    11. Nordic
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    12. Benelux
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    13. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
  9. APAC Pediatric Vaccines Market Size Analysis
    1. Introduction
    2. Pediatric Vaccines Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Monovalent
      2. Multivalent
    3. Pediatric Vaccines Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Live Attenuated Vaccines
      2. Inactivated Vaccines
      3. Subunit Vaccines
      4. Toxoid Vaccines
      5. Conjugate Vaccines
      6. Others
    4. Pediatric Vaccines Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Infectious Disease
      2. Cancer
      3. Allergy
      4. Pneumococcal Diseases
      5. Influenza
      6. Measles, Mumps, and Rubella (MMR)
      7. Others
    5. China
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    6. Korea
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    7. Japan
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    8. India
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    9. Australia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    10. Taiwan
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    11. South East Asia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    12. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
  10. Middle East and Africa Pediatric Vaccines Market Size Analysis
    1. Introduction
    2. Pediatric Vaccines Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Monovalent
      2. Multivalent
    3. Pediatric Vaccines Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Live Attenuated Vaccines
      2. Inactivated Vaccines
      3. Subunit Vaccines
      4. Toxoid Vaccines
      5. Conjugate Vaccines
      6. Others
    4. Pediatric Vaccines Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Infectious Disease
      2. Cancer
      3. Allergy
      4. Pneumococcal Diseases
      5. Influenza
      6. Measles, Mumps, and Rubella (MMR)
      7. Others
    5. UAE
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    6. Turkey
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    7. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    8. South Africa
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    9. Egypt
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    10. Nigeria
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    11. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
  11. LATAM Pediatric Vaccines Market Size Analysis
    1. Introduction
    2. Pediatric Vaccines Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Monovalent
      2. Multivalent
    3. Pediatric Vaccines Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Live Attenuated Vaccines
      2. Inactivated Vaccines
      3. Subunit Vaccines
      4. Toxoid Vaccines
      5. Conjugate Vaccines
      6. Others
    4. Pediatric Vaccines Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Infectious Disease
      2. Cancer
      3. Allergy
      4. Pneumococcal Diseases
      5. Influenza
      6. Measles, Mumps, and Rubella (MMR)
      7. Others
    5. Brazil
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    6. Mexico
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    7. Argentina
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    8. Chile
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    9. Colombia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    10. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
  12. Competitive Landscape
    1. Pediatric Vaccines Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Pfizer Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Sanofi
    3. GSK plc
    4. Merck & Co., Inc.
    5. AstraZeneca
    6. Johnson & Johnson Services Inc.
    7. Moderna, Inc.
    8. BioNTech SE
    9. Novavax, Inc.
    10. Valneva SE
    11. Daiichi Sankyo Company Limited
    12. Takeda Pharmaceutical Company Limited
    13. Serum Institute of India Pvt. Ltd.
    14. Bharat Biotech
    15. Indian Immunologicals Ltd.
    16. Zydus Group
    17. Sinovac
    18. Biological E Limited
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.